GuidelinesEAU Guidelines on Renal Cell Carcinoma: 2014 Update
Introduction
The European Association of Urology (EAU) Renal Cell Carcinoma (RCC) Guideline Panel has compiled these clinical guidelines to provide clinicians with evidence-based information and recommendations for the management of patients with RCC. The RCC panel is an international group consisting of clinicians with particular expertise in this field. To meet the requirements for a multidisciplinary approach, the panel has recently been reinforced by several experts, including a medical oncologist, pathologists, radiologists, a methodologist, biostatisticians, and members of patient advocacy groups. The EAU RCC guidelines were first published in 2000 [1], with a subsequent full update in 2006 and partial updates in 2007, 2008, 2009, 2010 [2], and 2013. The current 2014 document presents a full-text update and is fundamentally different from the versions published previously. The panel adopted Cochrane methodology and Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines [3] in undertaking systematic reviews (SRs) in 2011 to ensure that the evidence synthesis was performed in a robust, standardised, transparent, and reproducible manner. For the 2014 update, the panel has proceeded with the SR work in a stepwise fashion. The majority of sections have been updated based on SRs; however, a few sections of the document have been updated following a structured literature assessment, as shown in Table 1. As a result, the previous guideline has been completely revised and supplemented with a section on management of venous tumour thrombus. A detailed version of the current guideline including full references, level of evidence, and grade of recommendations is available at www.uroweb.org [4]. The focus for the next 2 yr is for the complete guidelines document to be based on SRs for evidence synthesis, as SRs represent the highest possible level of data work-up.
Section snippets
Evidence acquisition
All chapters of the 2014 RCC Guidelines publication have been updated. As mentioned in Table 1, the consistency of the data work-up differed between sections. For the parts of the guideline that have been updated by SR, the review methodology is outlined in detail in several ensuing publications [5], [6]. In brief, SRs of the literature were conducted in accordance with PRISMA guidelines [3]. Important topics and questions were prioritised by the panel for the present update. For each SR,
Evidence synthesis
The majority of the studies included in this guideline update are retrospective analyses that include some larger multicentre studies and well-designed controlled studies. As only a few RCTs are available, most of the data are not based on high levels of evidence. The exception was for systemic treatment of metastatic RCC (mRCC), for which several RCTs have been performed, resulting in recommendations based on higher levels of evidence.
Conclusions
These updated 2014 guidelines provide the current evidence base for the management of RCC according to the most robust and reliable standards. In contrast to previous versions, a multidisciplinary panel prioritised the importance of specific topics and questions, for which evidence synthesis was performed based on SRs. In addition, guideline recommendations were graded according to the 2009 Oxford Centre for Evidence-based Medicine Levels of Evidence. The aim of the panel is to strengthen the
References (77)
- et al.
EAU guidelines on renal cell carcinoma: the 2010 update
Eur Urol
(2010) - et al.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
J Clin Epidemiol
(2009) - et al.
A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer
Eur Urol
(2015) - et al.
Systematic review of adrenalectomy and lymph node dissection in locally advanced renal cell carcinoma
Eur Urol
(2013) - et al.
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012
Eur J Cancer
(2013) - et al.
Large prospective investigation of meat intake, related mutagens, and risk of renal cell carcinoma
Am J Clin Nutr
(2012) - et al.
Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis
Ann Oncol
(2012) - et al.
Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma
Eur Urol
(2003) - et al.
Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis
J Urol
(2003) - et al.
Contrast-enhanced ultrasound for diagnosis of prostate cancer and kidney lesions
Eur J Radiol
(2007)